Clinical Trial Update: PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of the PEP-CMV CMV antigen-targeted vaccine for newly diagnosed pediatric high-grade glioma, diffuse intrinsic pontine glioma, and recurr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Intrinsic Pontine Glioma
• High-grade Glioma
• Medulloblastoma

Drugs mentioned

• PEP-CMV vaccine (CMV antigen-targeted vaccine)

Snippet

Sponsor: Nationwide Children's Hospital | Conditions: High Grade Glioma, Diffuse Intrinsic Pontine Glioma | Phase 2 | Status: RECRUITING